US FDA QMSR Takes Effect: March 2026
News Regulatory Updates United States FDA QMSR
What the FDA Quality Management System Regulation means for medical device manufacturers aligning quality processes with ISO 13485 concepts.
US FDA QMSR Takes Effect: March 2026
The FDA Quality Management System Regulation (QMSR) became effective in February 2026. Manufacturers selling medical devices in the United States should review how their quality system procedures, records, and training demonstrate readiness for the new framework.
What to review
- The relationship between existing QMS procedures and ISO 13485-based requirements incorporated by the QMSR.
- Records for design controls, purchasing controls, production, CAPA, complaint handling, and management review.
- Training plans, supplier communication, and inspection-readiness evidence.
Practical impact
The work is not a document-renaming exercise. Manufacturers should identify procedural gaps, demonstrate effective implementation, and ensure that records are consistently available for inspection.
Source to monitor
Read the FDA QMSR information and the final rule materials.